Clinical Trial

Trial to Investigate GZ21T in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a double-blind, randomised, placebo-controlled trial designed to evaluate safety, tolerability, and pharmacokinetics (PK) after topical administration of single ascending doses of GZ21T in healthy volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-14.
Status change: Recruiting → Completed 2026-01-27
Trial Details
NCT Number NCT06888362
Lead Sponsor Genzada Pharmaceuticals USA, Inc.
Collaborators: CTC Clinical Trial Consultants AB
Conditions Actinic Keratosis
Enrollment 41 participants
Start Date 2024-08-19
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-28